DOCGO INC (DCGO) Stock Fundamental Analysis
NASDAQ:DCGO - Nasdaq - US2560861096 - Common Stock - Currency: USD
Taking everything into account, DCGO scores 4 out of 10 in our fundamental rating. DCGO was compared to 103 industry peers in the Health Care Providers & Services industry. DCGO has a great financial health rating, but its profitability evaluates not so good. DCGO has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year DCGO was profitable.
In the past year DCGO had a positive cash flow from operations.
Of the past 5 years DCGO 4 years were profitable.
In multiple years DCGO reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -0.15%, DCGO perfoms like the industry average, outperforming 47.57% of the companies in the same industry.
DCGO has a Return On Equity of -0.21%. This is comparable to the rest of the industry: DCGO outperforms 53.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.15% | ||
| ROE | -0.21% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DCGO's Profit Margin has declined in the last couple of years.
DCGO's Operating Margin has declined in the last couple of years.
The Gross Margin of DCGO (34.03%) is better than 63.11% of its industry peers.
In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for DCGO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.03% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DCGO has less shares outstanding
The debt/assets ratio for DCGO is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.33 indicates that DCGO is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of DCGO (2.33) is comparable to the rest of the industry.
DCGO has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
The Debt to FCF ratio of DCGO (0.55) is better than 90.29% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that DCGO is not too dependend on debt financing.
DCGO has a better Debt to Equity ratio (0.13) than 70.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 2.33 |
ROIC/WACCN/A
WACC8.22%
2.3 Liquidity
DCGO has a Current Ratio of 2.44. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO's Current ratio of 2.44 is amongst the best of the industry. DCGO outperforms 84.47% of its industry peers.
DCGO has a Quick Ratio of 2.44. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO has a Quick ratio of 2.44. This is amongst the best in the industry. DCGO outperforms 85.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.00%.
DCGO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.93% yearly.
The Revenue for DCGO has decreased by -26.01% in the past year. This is quite bad
The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
Revenue 1Y (TTM)-26.01%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
3.2 Future
The Earnings Per Share is expected to decrease by -37.99% on average over the next years. This is quite bad
DCGO is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -15.82% yearly.
EPS Next Y-233.38%
EPS Next 2Y-55.3%
EPS Next 3Y-37.99%
EPS Next 5YN/A
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 20.86, the valuation of DCGO can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of DCGO indicates a somewhat cheap valuation: DCGO is cheaper than 66.99% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, DCGO is valued a bit cheaper.
DCGO is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.86 | ||
| Fwd PE | N/A |
4.2 Price Multiples
90.29% of the companies in the same industry are more expensive than DCGO, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DCGO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.72 | ||
| EV/EBITDA | 5.96 |
4.3 Compensation for Growth
A cheap valuation may be justified as DCGO's earnings are expected to decrease with -37.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-55.3%
EPS Next 3Y-37.99%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.46
-0.03 (-2.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners59.61%
Inst Owner Change0%
Ins Owners6.96%
Ins Owner Change4.5%
Market Cap144.69M
Analysts78.46
Price Target3.11 (113.01%)
Short Float %6.55%
Short Ratio5.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-165.5%
Min EPS beat(2)-311.74%
Max EPS beat(2)-19.26%
EPS beat(4)1
Avg EPS beat(4)-84.64%
Min EPS beat(4)-311.74%
Max EPS beat(4)0.93%
EPS beat(8)2
Avg EPS beat(8)-66.93%
EPS beat(12)4
Avg EPS beat(12)-46.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.08%
Min Revenue beat(2)-9.68%
Max Revenue beat(2)-8.47%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)-0.57%
Revenue beat(8)4
Avg Revenue beat(8)0.9%
Revenue beat(12)7
Avg Revenue beat(12)1.96%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-39.6%
EPS NQ rev (1m)-6.46%
EPS NQ rev (3m)-407.75%
EPS NY rev (1m)-451.32%
EPS NY rev (3m)-11788.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-22.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.86 | ||
| Fwd PE | N/A | ||
| P/S | 0.28 | ||
| P/FCF | 1.72 | ||
| P/OCF | 1.6 | ||
| P/B | 0.47 | ||
| P/tB | 0.62 | ||
| EV/EBITDA | 5.96 |
EPS(TTM)0.07
EY4.79%
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)0.85
FCFY58.29%
OCF(TTM)0.91
OCFY62.64%
SpS5.25
BVpS3.12
TBVpS2.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.15% | ||
| ROE | -0.21% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.03% | ||
| FCFM | 16.2% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score5
Asset Turnover1.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 2.9 | ||
| Cap/Depr | 40.69% | ||
| Cap/Sales | 1.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 634.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z | 2.33 |
F-Score5
WACC8.22%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
EPS Next Y-233.38%
EPS Next 2Y-55.3%
EPS Next 3Y-37.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.01%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
EBIT growth 1Y-102.46%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-89.9%
EBIT Next 3Y-27.25%
EBIT Next 5YN/A
FCF growth 1Y516.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y824.48%
OCF growth 3YN/A
OCF growth 5YN/A